A Study to Investigate the Efficacy and Safety of Cobimetinib Plus Atezolizumab in Participants With Solid Tumors
Clinical trial NCT03264066 · COMPLETED
Trial details
- NCT number
- NCT03264066
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-23
- Primary completion
- 2020-06-25
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.